NephroGenex (NRX) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts NRX Hot Sheet
Join SI Premium – FREE
NephroGenex (NASDAQ: NRX) reported Q3 EPS of ($0.53), $0.12 better than the analyst estimate of ($0.65).
For earnings history and earnings-related data on NephroGenex (NRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- LTC Properties (LTC) PT Raised to $52 at RBC Capital
- DBS cuts Sea target as Shopee spending weighs on profit growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
